amgen
Entity, reached from Hormuz.
- Evidence
- 85 documents · 31 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 21 Jun 2026, last seen 8 Oct 2026
- Measured
- 18% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- IAM · 2026-09-30 · BMS’s Opdivo patent suit against Amgen adds to eventful 2026 for biosimilar spats (opens the source in a new tab)
- Fierce Biotech · 2026-09-30 · Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibody (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-24 · First of Amgen’s Phase III Sjögren’s disease trials succeeds (opens the source in a new tab)
- Endpoints News · 2026-09-23 · Amgen's Phase 3 Sjögren's win; Novartis' $900M radioligand deal (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-22 · Erste Group Bank Brokers Reduce Earnings Estimates for Amgen (opens the source in a new tab)
- BioPharma Dive · 2026-09-12 · Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use (opens the source in a new tab)
- 24/7 Wall St. · 2026-09-10 · Here Are Thursday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hyn… (opens the source in a new tab)
- Fierce Pharma · 2026-09-09 · Amgen’s DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer (opens the source in a new tab)
- 24/7 Wall St. · 2026-09-09 · Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14% (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-07 · HighTower Advisors LLC Sells 4,063 Shares of Amgen Inc. $AMGN (opens the source in a new tab)
1 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with merck (38 documents)seen together
- co-mentioned with eli lilly (33 documents)seen together
- co-mentioned with astrazeneca (27 documents)seen together
- co-mentioned with novartis (27 documents)seen together
- co-mentioned with pfizer (27 documents)seen together
- co-mentioned with roche (25 documents)seen together
- co-mentioned with bristol myers squibb (23 documents)seen together
- co-mentioned with fda (22 documents)seen together
- co-mentioned with abbvie (19 documents)seen together
- co-mentioned with bayer (18 documents)seen together